Works matching IS 00070920 AND DT 2023 AND VI 129 AND IP 1
Results: 20
Side effects of low-dose tamoxifen: results from a six-armed randomised controlled trial in healthy women.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 1, p. 61, doi. 10.1038/s41416-023-02293-z
- By:
- Publication type:
- Article
Deceptive measures of progress in the NHS long-term plan for cancer: case-based vs. population-based measures.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 1, p. 3, doi. 10.1038/s41416-023-02308-9
- By:
- Publication type:
- Article
Correction to: Reshaping the tumour immune microenvironment in solid tumours via tumour cell and immune cell DNA methylation: from mechanisms to therapeutics.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
TPX2 expression as a negative predictor of gemcitabine efficacy in pancreatic cancer.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 1, p. 175, doi. 10.1038/s41416-023-02295-x
- By:
- Publication type:
- Article
'Evaluation of adverse prognostic gene alterations & MRD positivity in BCR::ABL1-like B-lineage acute lymphoblastic leukaemia patients, in a resource-constrained setting.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 1, p. 143, doi. 10.1038/s41416-023-02294-y
- By:
- Publication type:
- Article
Integrated circulating tumour DNA and cytokine analysis for therapy monitoring of ALK-rearranged lung adenocarcinoma.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 1, p. 112, doi. 10.1038/s41416-023-02284-0
- By:
- Publication type:
- Article
Reshaping the tumour immune microenvironment in solid tumours via tumour cell and immune cell DNA methylation: from mechanisms to therapeutics.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 1, p. 24, doi. 10.1038/s41416-023-02292-0
- By:
- Publication type:
- Article
Anticipating changes in the HER2 status of breast tumours with disease progression—towards better treatment decisions in the new era of HER2-low breast cancers.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 1, p. 122, doi. 10.1038/s41416-023-02287-x
- By:
- Publication type:
- Article
Chemoradiotherapy versus triplet chemotherapy as initial therapy for T4b esophageal cancer: survival results from a multicenter randomized Phase 2 trial.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 1, p. 54, doi. 10.1038/s41416-023-02286-y
- By:
- Publication type:
- Article
NK cell activity and methylated HOXA9 ctDNA as prognostic biomarkers in patients with non-small cell lung cancer treated with PD-1/PD-L1 inhibitors.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 1, p. 135, doi. 10.1038/s41416-023-02285-z
- By:
- Publication type:
- Article
A Phase 1/2 trial of SRA737 (a Chk1 inhibitor) administered orally in patients with advanced cancer.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 1, p. 38, doi. 10.1038/s41416-023-02279-x
- By:
- Publication type:
- Article
Clinical biomarker-based biological aging and risk of cancer in the UK Biobank.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 1, p. 94, doi. 10.1038/s41416-023-02288-w
- By:
- Publication type:
- Article
Evaluation of DNA methylation biomarkers ASCL1 and LHX8 on HPV-positive self-collected samples from primary HPV-based screening.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 1, p. 104, doi. 10.1038/s41416-023-02277-z
- By:
- Publication type:
- Article
In silico enhancer mining reveals SNS-032 and EHMT2 inhibitors as therapeutic candidates in high-grade serous ovarian cancer.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 1, p. 163, doi. 10.1038/s41416-023-02274-2
- By:
- Publication type:
- Article
Biparatopic anti-HER2 drug radioconjugates as breast cancer theranostics.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 1, p. 153, doi. 10.1038/s41416-023-02272-4
- By:
- Publication type:
- Article
"Paradoxical neoantigenic mutations": not simply a driver vs passenger dualism.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Deep learning-based pathology signature could reveal lymph node status and act as a novel prognostic marker across multiple cancer types.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 1, p. 46, doi. 10.1038/s41416-023-02262-6
- By:
- Publication type:
- Article
Inequalities in cancer screening participation between adults with and without severe mental illness: results from a cross-sectional analysis of primary care data on English Screening Programmes.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 1, p. 81, doi. 10.1038/s41416-023-02249-3
- By:
- Publication type:
- Article
Modelled mortality benefits of multi-cancer early detection screening in England.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 1, p. 72, doi. 10.1038/s41416-023-02243-9
- By:
- Publication type:
- Article
The critical roles of m6A RNA methylation in lung cancer: from mechanism to prognosis and therapy.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 1, p. 8, doi. 10.1038/s41416-023-02246-6
- By:
- Publication type:
- Article